Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, has named Simon Li as General Manager, China. Based in Shanghai, Mr. Li will direct Kantar Health's growth strategy in the Chinese market, partnering with pharmaceutical and biotech companies to optimize their performance in this critical high-growth region.
"Simon is one of the most respected healthcare market research experts in China, and we are delighted to have someone of his caliber leading our business there," says Stephen Potts, Regional Director, Asia-Pacific, Middle East and Africa for Kantar Health. "Simon's local knowledge combined with Kantar Health's global expertise, products and services are a powerful combination, helping our customers take advantage of the major growth opportunities that China offers."
Mr. Li joins Kantar Health from IMS Health, where he was the Head of Primary Market Research, China. With almost two decades of healthcare market research experience in China, he has combined his market research expertise and understanding of the China healthcare market to help customers understand and navigate the Chinese regulatory and market environment -- and design the research programs to ensure their success in this important region.
"I am very excited to be joining Kantar Health and putting its powerful range of research and consulting solutions to work helping clients achieve their market goals in China," Mr. Li says. "With its scope of competencies, focus on customers' business issues and commitment to delivering practical business guidance, Kantar Health is uniquely positioned to ensure clients excel in the Chinese market."
About Kantar Health (www.kantarhealth.com)
As experts in pharmaceutical and biotechnology consulting and market research, Kantar Health offers unique insights and products that deliver proven results for marketing insights, brand marketing, business development and health economics and outcomes professionals, including:
? The greatest breadth and depth of epidemiology information in the world, spanning patient-reported outcomes and patient care by country, therapy area, specialist -- or whatever combination of data you require
? Unmatched experience in the complex oncology market that encompasses business development, clinical management, emerging technologies, marketing and sales, payers and providers, reimbursement and strategic and product planning
? A unique global source of KOLs for multiple therapy areas
Kantar Health's team combines doctorate-level scientific expertise with strong business know-how, ensuring that solutions are both evidence-based and commercially focused. By uniting industry leaders MattsonJack, TNS Healthcare, Consumer Health Sciences and Ziment, we offer a wide range of expertise in emerging as well as established markets, spanning the product life cycle from product portfolio management to licensing, market access to brand and reputation management, detailing to clinical research, patient outcomes and sales force effectiveness to health and safety. And as part of WPP, the largest marketing agency in the world, Kantar Health can leverage the power of the global group with shared offline and online research methodologies but remain culturally specific and nimble. Kantar Health focuses on getting you the best return.
Contact Information
For more information on Kantar Health, please contact:
Paula Paradise
Vice President of Global Marketing
paula.paradise@kantarhealth.com
+1-484-442-1431